Skip to content
Home - Media - Press releases - 2003    
24 March 2003
NEW DATA BEING PRESENTED ON CRESTOR AND EXANTA: IMPORTANT DIARY DATE

Data on two of AstraZeneca’s exciting new products, Crestor (rosuvastatin) and Exanta (ximelagatran), will be presented during the ACC (American College of Cardiology Congress).

Two press briefings will take place on Wednesday 2 April 2003:

Crestor and Exanta Webcasts

CRESTOR webcast - (webcast no longer available)

EXANTA webcast - (webcast no longer available)

Telephone dial-up

In addition to the webcast there will be a telephone dial-up enabling you to listen to the presentations and participate in the Q & A session while viewing the slides on the internet. To use this facility you will need to call +44 (0) 1296 480 180 and insert the pin number 938926# a few minutes prior to the start of the press briefings on Wednesday 2 April.

To view either of these webcasts you will need either Window Media Player Version 7.1 (or higher) or Real Media Player Version 8. More information available at www.AstraZenecaPressOffice.com .

*10.45 CST will be 17.45 BST, 18.45 CET and 11.45 EST on 2 April 2003

**12.15 CST will be 19.15 BST, 20.15 CET and 13.15EST on 2 April 2003

If you have any further questions please do not hesitate to contact the following individuals:

Further enquires to:

Media Enquiries

Emily Denney
+44 (0)20 7304 5034

Steve Brown
+44 (0)20 7304 5033


Crestor and, Exanta are trademarks, property of the AstraZeneca group of companies.

AstraZeneca websites
Search